LH
US EQUITY
Health Care
Health Care Services
CIK: 920148
Labcorp (LH) Quant Factor Diagnostic & Fair Value Model
Labcorp (Ticker: LH) is listed in the Health Care sector (Health Care Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$328.95
-0.30%
Latest Close (2026-10-23)
Market Cap: $47.29B
P/E Ratio: 22.6
Momentum Strength
3M / 12M
+9.22%
1M: +6.47%
12M: +16.30%
Quality (ROE)
Point-in-Time
+13.86%
Trailing Return on Equity
Technical Trend
RSI 14
72.9
SMA50: $320.74
SMA200: $285.16
Valuation Multiplier
Trailing
22.6
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
LH trades within a typical sector multiple band (22.6x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 8/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 920148 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $3.73B | $298.70M | $637.00M | $3.64 |
| 10-Q | 2026-03-31 | 2026-08-05 | $3.54B | $277.80M | $191.50M | $3.35 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $3.53B | $237.90M | $639.10M | $2.84 |
| 10-Q | 2025-03-31 | 2026-08-05 | $3.35B | $212.80M | $18.50M | $2.52 |
| 10-K | 2025-12-31 | 2026-02-24 | $13.95B | $876.50M | $1.64B | $10.46 |
| 10-K | 2024-12-31 | 2026-02-24 | $13.01B | $746.00M | $1.59B | $8.84 |
| 10-K | 2023-12-31 | 2026-02-24 | $12.16B | $418.00M | $1.33B | $4.77 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Labcorp (LH) valuation multiples, momentum factors, and point-in-time filing conventions.
How should LH's current valuation multiple be interpreted? ↓
LH trades at a trailing P/E of 22.6x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are LH's key momentum and technical factor indicators? ↓
As of the latest close, LH shows a 1-month return of +6.47%, 3-month return of +9.22%, and 12-month return of +16.30%, with a 14-day RSI of 72.9. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for LH? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can LH be incorporated into systematic factor models? ↓
LH can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.